Cancer Research Cancer Medicine 8  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 903-906, February 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakamoto, N.
Right arrow Articles by Osada, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakamoto, N.
Right arrow Articles by Osada, Y.

Inhibition of Angiogenesis and Tumor Growth by a Synthetic Laminin Peptide, CDPGYIGSR-NH2

Noritsugu Sakamoto, Michio Iwahana, Noriko G. Tanaka1 and Yasuaki Osada

Research Institute, Daiichi Pharmaceutical Co., Ltd., 16-13, Kitakasai 1-chome, Edogawa-ku, Tokyo 134, Japan

A laminin-derived synthetic peptide, Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 (CDPGYIGSR-NH2), containing an active site for cell binding inhibited both angiogenesis and solid tumor growth. It potently suppressed both embryonic angiogenesis of the chick chorioallantoic membrane and migration of vascular endothelial cells induced by a tumor-conditioned medium but neither the in vitro proliferation of endothelial cells nor that of tumor cells. Additionally, in in vivo tests, CDPGYIGSR-NH2 markedly inhibited both the growth of s.c. solid tumor of Sarcoma 180 and that of Lewis lung carcinoma (3LL) in the lungs. On the contrary, ascitic tumor growth of Sarcoma 180 was not affected by this peptide, even though the same cell source was used. It was concluded that solid tumor growth inhibition by CDPGYIGSR-NH2 was due not to a direct effect on cell growth but to an antiangiogenic effect mediated by the inhibition of endothelial cell migration.

1 To whom requests for reprints should be addressed.

Received 7/31/90. Accepted 11/20/90.




This article has been cited by other articles:


Home page
JDRHome page
C. E. Semino
Self-assembling Peptides: From Bio-inspired Materials to Bone Regeneration
Journal of Dental Research, July 1, 2008; 87(7): 606 - 616.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Sharma, T. Tran, G. L. Stelmack, K. McNeill, R. Gosens, M. M. Mutawe, H. Unruh, W. T. Gerthoffer, and A. J. Halayko
Expression of the dystrophin-glycoprotein complex is a marker for human airway smooth muscle phenotype maturation
Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L57 - L68.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Hibino, M. Shibuya, M. P. Hoffman, J. A. Engbring, R. Hossain, M. Mochizuki, S. Kudoh, M. Nomizu, and H. K. Kleinman
Laminin {alpha}5 Chain Metastasis- and Angiogenesis-Inhibiting Peptide Blocks Fibroblast Growth Factor 2 Activity by Binding to the Heparan Sulfate Chains of CD44
Cancer Res., November 15, 2005; 65(22): 10494 - 10501.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Hibino, M. Shibuya, J. A. Engbring, M. Mochizuki, M. Nomizu, and H. K. Kleinman
Identification of an Active Site on the Laminin {alpha}5 Chain Globular Domain That Binds to CD44 and Inhibits Malignancy
Cancer Res., July 15, 2004; 64(14): 4810 - 4816.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. L. Ponce, S. Hibino, A. M. Lebioda, M. Mochizuki, M. Nomizu, and H. K. Kleinman
Identification of a Potent Peptide Antagonist to an Active Laminin-1 Sequence That Blocks Angiogenesis and Tumor Growth
Cancer Res., August 15, 2003; 63(16): 5060 - 5064.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Singhal, R. Wiewrodt, L. D. Malden, K. M. Amin, K. Matzie, J. Friedberg, J. C. Kucharczuk, L. A. Litzky, S. W. Johnson, L. R. Kaiser, et al.
Gene Expression Profiling of Malignant Mesothelioma
Clin. Cancer Res., August 1, 2003; 9(8): 3080 - 3097.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Engbring, M. P. Hoffman, A. J. Karmand, and H. K. Kleinman
The B16F10 Cell Receptor for a Metastasis-promoting Site on Laminin-1 Is a Heparan Sulfate/Chondroitin Sulfate-containing Proteoglycan
Cancer Res., June 1, 2002; 62(12): 3549 - 3554.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Ochoa, P. Montes de Oca, J. C. Rivera, Z. Dueñas, G. Nava, G. M. de la Escalera, and C. Clapp
Expression of Prolactin Gene and Secretion of Prolactin by Rat Retinal Capillary Endothelial Cells
Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1639 - 1645.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
I. B. DeRoock, M. E. Pennington, T. C. Sroka, K. S. Lam, G. T. Bowden, E. L. Bair, and A. E. Cress
Synthetic Peptides Inhibit Adhesion of Human Tumor Cells to Extracellular Matrix Proteins
Cancer Res., April 1, 2001; 61(8): 3308 - 3313.
[Abstract] [Full Text]


Home page
JCOHome page
H. A. Fine, W. D. Figg, K. Jaeckle, P. Y. Wen, A. P. Kyritsis, J. S. Loeffler, V. A. Levin, P. M. Black, R. Kaplan, J. M. Pluda, et al.
Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas
J. Clin. Oncol., February 14, 2000; 18(4): 708 - 708.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kakolyris, A. Giatromanolaki, M. Koukourakis, I. M. Leigh, V. Georgoulias, P. Kanavaros, E. Sivridis, K. C. Gatter, and A. L. Harris
Assessment of Vascular Maturation in Non-Small Cell Lung Cancer Using a Novel Basement Membrane Component, LH39: Correlation with p53 and Angiogenic Factor Expression
Cancer Res., November 1, 1999; 59(21): 5602 - 5607.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Z. Duenas, L. Torner, A. M. Corbacho, A. Ochoa, G. Gutierrez-Ospina, F. Lopez-Barrera, F. A. Barrios, P. Berger, Gonzalo Martinez de la Escalera, and C. Carmen
Inhibition of Rat Corneal Angiogenesis by 16-kDa Prolactin and by Endogenous Prolactin-like Molecules
Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2498 - 2505.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I.-C. Kang, Y.-D. Lee, and D.-S. Kim
A Novel Disintegrin Salmosin Inhibits Tumor Angiogenesis
Cancer Res., August 1, 1999; 59(15): 3754 - 3760.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. L. Ponce, M. Nomizu, M. C. Delgado, Y. Kuratomi, M. P. Hoffman, S. Powell, Y. Yamada, H. K. Kleinman, and K. M. Malinda
Identification of Endothelial Cell Binding Sites on the Laminin {gamma}1 Chain
Circ. Res., April 2, 1999; 84(6): 688 - 694.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. M. Malinda, M. Nomizu, M. Chung, M. Delgado, Y. Kuratomi, Y. Yamada, H. K. Kleinman, and M. L. Ponce
Identification of laminin {alpha}1 and ß1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting
FASEB J, January 1, 1999; 13(1): 53 - 62.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Nomizu, Y. Kuratomi, K. M. Malinda, S.-Y. Song, K. Miyoshi, A. Otaka, S. K. Powell, M. P. Hoffman, H. K. Kleinman, and Y. Yamada
Cell Binding Sequences in Mouse Laminin alpha 1 Chain
J. Biol. Chem., December 4, 1998; 273(49): 32491 - 32499.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
I Ozaki, K Yamamoto, T Mizuta, S Kajihara, N Fukushima, Y Setoguchi, F Morito, and T Sakai
Differential expression of laminin receptors in human hepatocellular carcinoma
Gut, December 1, 1998; 43(6): 837 - 842.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nomizu, Y. Kuratomi, S.-Y. Song, M. L. Ponce, M. P. Hoffman, S. K. Powell, K. Miyoshi, A. Otaka, H. K. Kleinman, and Y. Yamada
Identification of Cell Binding Sequences in Mouse Laminin gamma 1 Chain by Systematic Peptide Screening
J. Biol. Chem., December 19, 1997; 272(51): 32198 - 32205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Soker, S. Gollamudi-Payne, H. Fidder, H. Charmahelli, and M. Klagsbrun
Inhibition of Vascular Endothelial Growth Factor (VEGF)-induced Endothelial Cell Proliferation by a Peptide Corresponding to the Exon 7-Encoded Domain of VEGF165
J. Biol. Chem., December 12, 1997; 272(50): 31582 - 31588.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M.F. Khan and D. J. Falcone
Role of Laminin in Matrix Induction of Macrophage Urokinase-type Plasminogen Activator and 92-kDa Metalloproteinase Expression
J. Biol. Chem., March 28, 1997; 272(13): 8270 - 8275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Nelson, W. N. Scott, W. E. Allen, D. J. Wilson, P. Harriott, N. V. McFerran, and B. Walker
Murine Epidermal Growth Factor Peptide (33-42) Binds to a YIGSR-specific Laminin Receptor on both Tumor and Endothelial Cells
J. Biol. Chem., October 18, 1996; 271(42): 26179 - 26186.
[Abstract] [Full Text] [PDF]


Home page
J Oncol Pharm PractHome page
K. R. Dover and A. W. Valley
Review : Angiogenesis: A new target for antineoplastic therapy
Journal of Oncology Pharmacy Practice, January 1, 1996; 2(1): 43 - 60.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
A. Canfield and A. Schor
Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells
J. Cell Sci., January 2, 1995; 108(2): 797 - 809.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.